Skip to main contentSkip to navigation
Sirius Investors
OncoSec Medical Incorporated

OncoSec Medical Incorporated

ONCSQ
OTCHealthcare

OncoSec Medical Incorporated (ONCSQ) Investment Research Dashboard

About OncoSec Medical Incorporated (ONCSQ) stock analysis

Get live ONCSQ stock price $0.00, comprehensive OncoSec Medical Incorporated stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time ONCSQ stock data and investment insights.

0.00
0.00%Today
Market Cap
596
Volume
123.29K
52W High
0.00
52W Low
0.00

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

OncoSec Medical Incorporated was an immuno-oncology firm focused on the advanced stages of drug development. Its primary mission involved devising, perfecting, and bringing to market DNA-based treatments administered directly into tumors. These thera...

Company Information

CEO
Sector
Healthcare
Industry
Biotechnology
Employees
40

Contact Information

Address
24 North Main Street
Country
US

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Higher growth potential with elevated volatility (Beta: 9.82)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for OncoSec Medical Incorporated shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for OncoSec Medical Incorporated
  • Investors should consider how OncoSec Medical Incorporated fits within their overall portfolio allocation

Market Cap

596

Beta

9.82

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

72/100 ⭐⭐⭐⭐⭐

Overall
-0.1%
NYSE
-0.1%
NASDAQ
-0.1%
Sector1D1W1MP/EScore
Consumer Defensive+1.3%+3.3%+2.2%29.2
88/100⭐⭐⭐⭐⭐
Financial Services-0.1%+0.8%+2.0%19.2
86/100⭐⭐⭐⭐⭐
Communication Services+0.4%-1.6%+2.0%22.1
74/100⭐⭐⭐⭐⭐
Healthcare-0.1%+0.5%+0.8%23.5
72/100⭐⭐⭐⭐⭐
Basic Materials-0.7%+0.1%-1.3%25.0
60/100⭐⭐⭐⭐
Energy-0.4%-2.0%-2.4%19.5
50/100⭐⭐⭐
Utilities-1.8%-0.7%-5.2%27.5
37/100⭐⭐
Real Estate-1.6%-1.1%-3.5%29.4
36/100⭐⭐
Industrials-0.3%-0.5%-10.6%30.4
22/100
Consumer Cyclical-0.3%-2.3%-6.5%43.1
17/100
Technology-1.9%-4.0%-9.4%41.9
7/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.